Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS
about
In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosidesSelective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms.Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic FibrosisResponses of Pseudomonas aeruginosa to antimicrobialsTranscriptome of Dickeya dadantii infecting Acyrthosiphon pisum reveals a strong defense against antimicrobial peptidesBroad-substrate screen as a tool to identify substrates for bacterial Gcn5-related N-acetyltransferases with unknown substrate specificityThe two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRSThe MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQTwo-component regulatory systems in Pseudomonas aeruginosa: an intricate network mediating fimbrial and efflux pump gene expressionThe transcriptional regulator CzcR modulates antibiotic resistance and quorum sensing in Pseudomonas aeruginosaThe culturable soil antibiotic resistome: a community of multi-drug resistant bacteriaEvolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneA broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.Contribution of bacterial outer membrane vesicles to innate bacterial defense.Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.An orphan chemotaxis sensor regulates virulence and antibiotic tolerance in the human pathogen Pseudomonas aeruginosa.Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD)The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibilityTranscriptome profiling reveals links between ParS/ParR, MexEF-OprN, and quorum sensing in the regulation of adaptation and virulence in Pseudomonas aeruginosa.Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides.Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.Pseudomonas aeruginosa: resistance to the maxAmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patientsImpact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results.Large Preferred Region for Packaging of Bacterial DNA by phiC725A, a Novel Pseudomonas aeruginosa F116-Like BacteriophagePharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated EfficacyBacterial danger sensing.Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?Characterization of Polymyxin B Biodistribution and Disposition in an Animal ModelMechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives
P2860
Q24599890-47E65DAD-6B01-4DF2-B9FC-F852D100EAD5Q27331155-ACFFADE9-C8FF-4868-8EE2-4C387E506B53Q28076246-57D116B2-47E4-43C4-A3ED-BF58EB48014EQ28305587-9EE5660B-B8E8-4E1F-A60E-677C017D4CC2Q28485076-DAB3D081-1C4C-47B4-A408-89F5A5A5E25DQ28485785-CF10803D-5731-4D26-932F-1679316F9049Q28492572-A9B4B3B2-F9B1-43FD-983C-DAAD2A42941FQ28492677-C5FAD438-8E5A-4E61-884F-6CC658E52FEEQ28492999-21BAA4DE-F641-4D0F-983E-F3E138F5C31BQ28493171-9B0D6F36-0B91-4CE3-A350-ED820867D09AQ28533846-E7B47269-4CAA-42B7-8D2B-50731DD8CA69Q33911762-D6F9689F-C5FE-49E7-9892-1599C03986FFQ34057449-D58FD407-F5C8-4761-8DB7-EAF059DE2BF1Q34088577-8CC2278D-A054-476F-9FE4-6CEA6F0D352AQ34163308-1282450E-7CBD-466C-AB36-2CB915745E4BQ34341210-11F11107-D65C-4018-B3D4-B131501D9ABDQ34346283-592C314C-F052-4959-8261-6EB4FEE11E5EQ34369356-4DEFE009-DEC1-4C71-BF53-FC87FEF38E1BQ34446329-3C434457-067A-4B11-9B49-8C8C908121C9Q34778507-A2D8B849-8E16-407B-9A9D-84F663E1FDF2Q34922676-7EA5633D-6757-46CE-9718-818E893A7F3AQ34986994-F94FE939-2C12-4FAD-AEB3-E4181D03BBDFQ34989010-7BB9D135-8BCA-40BF-8579-2523C683A226Q35008777-BB803F6E-8EB3-4552-8CC0-8EE74C939FB5Q35070095-3BD3E182-65EA-4E4F-8541-BC81C1FFD7A3Q35084559-636CBBFC-5295-4124-A5A1-A4EF9BF45EB2Q35106217-E9BB32E5-249C-41FD-95CF-B843D62887A1Q35139454-10D7434A-81EC-4874-93C7-09BF50785843Q35168882-0393AF69-A061-4372-BA4D-5B4C890A3901Q35432770-F42C4EE1-AA6C-40F9-B5D4-DBABF599E376Q35482558-1EE46A8B-9FC3-4769-923D-C2D64BB696B1Q35598578-B5478D43-7A9A-46F1-982C-738B1E28C419Q36018883-9E4F648A-4362-47FD-B4E3-7D735D0A33A9Q36118781-393AB058-94EE-4414-A8BF-8BAD285D230CQ36242867-067012FF-85A2-40F7-A424-4B42FFA81023Q36290620-C80AE0F9-2302-41CF-8D7E-1F6AAADCC1B8Q36315932-89E146DB-D785-4883-8854-27F61D9E049BQ36335694-859BB74D-36AA-4C1B-AFD2-40ED0C5E5D80Q36571918-EB652E8F-7FCB-497B-A0F4-78F48ADB047EQ36575916-14E872F9-98A3-40A4-B69E-0C5CD05CD771
P2860
Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS
description
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im August 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/08/01)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/08/01)
@nl
наукова стаття, опублікована в серпні 2010
@uk
مقالة علمية (نشرت في أغسطس 2010)
@ar
name
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@ast
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@en
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@nl
type
label
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@ast
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@en
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@nl
prefLabel
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@ast
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@en
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@nl
P2093
P2860
P921
P3181
P356
P1476
Adaptive resistance to the "la ...... nt regulatory system ParR-ParS
@en
P2093
Irith Wiegand
Joseph B. McPhee
Lucía Fernández
Manjeet Bains
W. James Gooderham
P2860
P304
P3181
P356
10.1128/AAC.00242-10
P407
P577
2010-08-01T00:00:00Z